Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2915 ARTíCULOS , VIENDO DEL 151 AL 165

PUBMED

Longitudinal Metabolomics Profiling of Parkinson's Disease-Related α-Synuclein A53T Transgenic Mice.

Chen X, Xie C, Sun L, Ding J, Cai H.

PLoS One. 2015 Aug 28;10(8):e0136612. doi: 10.1371/journal.pone.0136612.

0

0

0

PUBMED

Motivational Modulation of Self-Initiated and Externally Triggered Movement Speed Induced by Threat of Shock: Experimental Evidence for Paradoxical Kinesis in Parkinson's Disease.

McDonald LM, Griffin HJ, Angeli A, Torkamani M, Georgiev D, Jahanshahi M.

PLoS One. 2015 Aug 18;10(8):e0135149. doi: 10.1371/journal.pone.0135149.

0

0

0

PUBMED

An Emerging Era in the Management of Parkinson's Disease: Wearable Technologies and the Internet of Things.

Pasluosta CF, Gassner H, Winkler J, Klucken J, Eskofier BM.

IEEE J Biomed Health Inform. 2015 Nov;19(6):1873-81. doi: 10.1109/JBHI.2015.2461555. Review.

0

0

0

PUBMED

Severity of orthostatic hypotension in the course of Parkinson's disease: no correlation with the duration of the disease.

Jost WH, Augustis S.

Parkinsonism Relat Disord. 2015 Mar;21(3):314-6. doi: 10.1016/j.parkreldis.2014.12.016.

0

0

0

PUBMED

Unexpected dual task benefits on cycling in Parkinson disease and healthy adults: a neuro-behavioral model.

Altmann LJ, Stegemöller E, Hazamy AA, Wilson JP, Okun MS, McFarland NR, Wagle Shukla A, Hass CJ.

PLoS One. 2015 May 13;10(5):e0125470. doi: 10.1371/journal.pone.0125470.

0

0

0

PUBMED

The sirtuin-2 inhibitor AK7 is neuroprotective in models of Parkinson's disease but not amyotrophic lateral sclerosis and cerebral ischemia.

Chen X, Wales P, Quinti L, Zuo F, Moniot S, Herisson F, Rauf NA, Wang H, Silverman RB, Ayata C, Maxwell MM, Steegborn C, Schwarzschild MA, Outeiro TF, Kazantsev AG.

PLoS One. 2015 Jan 21;10(1):e0116919. doi: 10.1371/journal.pone.0116919.

0

0

0

PUBMED

Analysis of Parkinson's disease pathophysiology using an integrated genomics-bioinformatics approach.

Fu LM, Fu KA.

Pathophysiology. 2015 Mar;22(1):15-29. doi: 10.1016/j.pathophys.2014.10.002.

0

0

0

PUBMED

Continuous infusion of apomorphine in patients with advanced Parkinson's disease and different degrees of functional disability.

Salazar G, Martín J, Fragoso M, Font MA.

Neurologia. 2015 Dec 14. pii: S0213-4853(15)00229-7. doi: 10.1016/j.nrl.2015.10.001. [Epub ahead of print] English, Spanish. No abstract available.

0

0

0

PUBMED

Parkinson's Disease Genetic Loci in Rapid Eye Movement Sleep Behavior Disorder.

Gan-Or Z, Girard SL, Noreau A, Leblond CS, Gagnon JF, Arnulf I, Mirarchi C, Dauvilliers Y, Desautels A, Mitterling T, Cochen De Cock V, Frauscher B, Monaca C, Hogl B, Dion PA, Postuma RB, Montplaisir

J Mol Neurosci. 2015 Jul;56(3):617-22. doi: 10.1007/s12031-015-0569-7.

0

0

0

PUBMED

The wrong James Parkinson.

Stott SR.

Pract Neurol. 2015 Apr;15(2):148. doi: 10.1136/practneurol-2014-001043. No abstract available.

0

0

0

PUBMED

Comparison of a Profile and Multi-Profile Best Worst Scaling Task: a Preference Study in Parkinson's Patients.

Groothuis-Oudshoorn CG, Weernink MG, van Til JA.

Value Health. 2015 Nov;18(7):A714. doi: 10.1016/j.jval.2015.09.2693. No abstract available.

0

0

0

PUBMED

Intraventricular Sialidase Administration Enhances GM1 Ganglioside Expression and Is Partially Neuroprotective in a Mouse Model of Parkinson's Disease.

Schneider JS, Seyfried TN, Choi HS, Kidd SK.

PLoS One. 2015 Dec 2;10(12):e0143351. doi: 10.1371/journal.pone.0143351.

0

0

0

PUBMED

Distinct phenotypes of speech and voice disorders in Parkinson's disease after subthalamic nucleus deep brain stimulation.

Tsuboi T, Watanabe H, Tanaka Y, Ohdake R, Yoneyama N, Hara K, Nakamura R, Watanabe H, Senda J, Atsuta N, Ito M, Hirayama M, Yamamoto M, Fujimoto Y, Kajita Y, Wakabayashi T, Sobue G.

J Neurol Neurosurg Psychiatry. 2015 Aug;86(8):856-64. doi: 10.1136/jnnp-2014-308043.

0

0

0

PUBMED

Quantitative Motor Performance and Sleep Benefit in Parkinson Disease.

van Gilst MM, van Mierlo P, Bloem BR, Overeem S.

Sleep. 2015 Oct 1;38(10):1567-73. doi: 10.5665/sleep.5048.

0

0

0

PUBMED

Validation of an ambulatory capacity measure in Parkinson disease: a construct derived from the Unified Parkinson's Disease Rating Scale.

Parashos SA, Elm J, Boyd JT, Chou KL, Dai L, Mari Z, Morgan JC, Sudarsky L, Wielinski CL.

J Parkinsons Dis. 2015;5(1):67-73. doi: 10.3233/JPD-140405.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy